UnitedHealth Group (NYSE:UNH) Issues FY25 Earnings Guidance

UnitedHealth Group (NYSE:UNH) issued an update on its FY25 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $29.50-$30.00 for the period, compared to the consensus earnings per share estimate of $29.92. The company issued revenue guidance of $450-$455 billion, compared to the consensus revenue estimate of $428.74 billion.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research reports. KeyCorp assumed coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target on the stock. HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday. Bank of America decreased their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Finally, Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $621.58.

UnitedHealth Group Trading Down 0.5 %

Shares of NYSE:UNH traded down $3.29 on Tuesday, hitting $605.23. 2,229,536 shares of the company’s stock were exchanged, compared to its average volume of 3,848,493. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The stock has a market capitalization of $556.98 billion, a price-to-earnings ratio of 39.43, a price-to-earnings-growth ratio of 1.79 and a beta of 0.58. The business’s 50 day simple moving average is $585.43 and its two-hundred day simple moving average is $556.65. UnitedHealth Group has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the firm posted $6.56 earnings per share. Analysts anticipate that UnitedHealth Group will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.39%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.